Finance

Beta
Lists
REPCF:OTCMKTS
RepliCel Life Sciences Inc
$0.00010
0.00%
(0.00) 1D
Apr 6, 12:04:36 PM GMT-4  ·   USD
All symbols
SymbolPriceChange% Change
Generating top insights for REPCF...
Mkt. cap
7.36K
Volume
0.00
52-wk high
$0.00
52-wk low
$0.00
EPS
-$0.00
Shares outstanding
70.01M
No. of employees
1
Mkt. cap
7.36K
Volume
0.00
52-wk high
$0.00
52-wk low
$0.00
EPS
-$0.00
Shares outstanding
70.01M
No. of employees
1
News stories
From sources across the web
Profile
RepliCel Life Sciences is a Canadian regenerative medicine company based in Vancouver, British Columbia. The company focuses on development of cell therapies using a patient's own cells. The company has treatment development activities targeting chronic tendon injuries which have failed to heal properly, and hair restoration. The company's expertise lies in isolation and exploitation of different cell populations found in the human hair follicle. The company's business model is focused on establishing proof-of-concept for treatments leading to acquisition by a larger company. An alternative business model has been reported which does not involve acquisition but rather partnership where technologies and methods are licensed to a partner which will commercialize them. Wikipedia
About RepliCel Life Sciences Inc
CEO-
Employees1
Founded1967
HeadquartersVancouver, British Columbia, Canada
SectorHealth care
Websitereplicel.com
Previous reportsAll values in CAD
Loading Previous Earnings...
Income statement
Revenue
Net income
All values in CAD
Jun 2025
Sep 2025
Dec 2025
Mar 2026
Revenue
-
-
-
88.43K
Cost of goods sold
-
-
-
-
Cost of revenue
-
-
-
-
Research and development expenses
-
2.31K
-
-
Total research and development expenses
-
-
-
-
Selling, general, and admin expenses
21.72K
5.25K
-
10.25K
Operating expense
21.72K
7.56K
-
10.25K
Total operating expenses
21.72K
7.56K
-
10.25K
Operating income
-21.72K
-7.56K
-
78.18K
Other non operating income
-
-
-
-114.63K
EBT including unusual items
-28.65K
-25.10K
-
-47.46K
EBT excluding unusual items
-28.65K
-25.10K
-
-47.46K
Income tax expense
-
-
-
-
Effective tax rate
-
-
-
-
Other operating expenses
-
-
-
-
Net income
-28.65K
-25.10K
-
-47.46K
Net profit margin
-
-
-
-53.67%
Earnings per share
-
-
-
-
Interest and investment income
-
-
-
-
Interest expense
-6.93K
-17.54K
-
-11.48K
Net interest expenses
-6.93K
-17.54K
-
-11.48K
Depreciation and amortization charges
-
-
-
-
EBITDA
-21.58K
-7.42K
-
-
Gain or loss from assets sale
1.65K
-
-
-
AI content may include mistakes. Learn more
HelpSend feedbackPrivacyTermsDisclaimer

Research

AI content may include mistakes. Learn more
HelpSend feedbackPrivacyTermsDisclaimer